ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 127 filers reported holding ANI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,852 | +5.6% | 4,200 | -47.5% | 0.00% | – |
| Q1 2022 | $231,000 | -21.7% | 8,000 | +27.0% | 0.00% | – |
| Q4 2021 | $295,000 | +2.1% | 6,300 | -37.6% | 0.00% | – |
| Q4 2020 | $289,000 | -55.1% | 10,100 | -11.4% | 0.00% | -100.0% |
| Q3 2018 | $644,000 | -28.2% | 11,400 | -26.0% | 0.00% | 0.0% |
| Q2 2018 | $897,000 | 0.0% | 15,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $897,000 | +7.3% | 15,400 | +18.7% | 0.00% | -33.3% |
| Q4 2017 | $836,000 | -38.6% | 12,978 | -55.0% | 0.00% | -50.0% |
| Q2 2017 | $1,362,000 | -37.8% | 28,854 | -34.5% | 0.01% | -50.0% |
| Q1 2017 | $2,188,000 | +534.2% | 44,065 | +673.9% | 0.01% | +500.0% |
| Q4 2016 | $345,000 | -87.3% | 5,694 | -88.2% | 0.00% | -86.7% |
| Q2 2016 | $2,719,000 | – | 48,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 328,494 | $15,137,000 | 4.72% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $13,824,000 | 2.78% |
| Mesirow Financial Investment Management, Inc. | 12,277 | $566,000 | 1.63% |
| Parkman Healthcare Partners LLC | 137,226 | $6,323,000 | 1.40% |
| Global Alpha Capital Management Ltd. | 284,831 | $13,125,000 | 1.27% |
| Stonepine Capital Management, LLC | 52,290 | $2,410,000 | 1.11% |
| 1492 Capital Management LLC | 43,611 | $2,010,000 | 0.99% |
| MARATHON CAPITAL MANAGEMENT | 74,770 | $3,445,000 | 0.81% |
| Walthausen & Co., LLC | 61,456 | $2,832,000 | 0.74% |
| Rubric Capital Management LP | 307,557 | $14,172,000 | 0.67% |